Form4.ai tracks every SEC insider trade in real time. See every NTLA insider filing with a free account — no card.
See every NTLA insider filing — free account, no card.
Free accountIntellia Therapeutics, Inc. (NTLA) has 4 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $418K. Most recent filing: Nov. 3, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Nov 3, 2026 SEC filing | LEONARD JOHN M President and CEO | Sold | $107,910 | — |
| Oct 28, 2026 SEC filing | Marantz Jing L. EVP, Chief Medical Officer | Grant / award | — | — |
| Oct 6, 2026 SEC filing | Dube Michael P VP, Chief Accounting Officer | Sold | $23,170 | — |
Create a free account to see all 4 NTLA filings from the last 90 days. No card needed.
Create free accountWant NTLA insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.